Global Insomnia Therapeutics Drugs Market Insights and Forecast to 2028

Report ID: 1750187 | Published Date: May 2024 | No. of Page: 111 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Benzodiazepines
        1.2.3 Nonbenzodiazepines
        1.2.4 Antidepressants
        1.2.5 Orexin Antagonists
        1.2.6 Melatonin Antagonists
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Prescription
        1.3.3 Over-the-Counter (OTC)
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Insomnia Therapeutics Drugs Market Perspective (2017-2028)
    2.2 Insomnia Therapeutics Drugs Growth Trends by Region
        2.2.1 Insomnia Therapeutics Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Insomnia Therapeutics Drugs Market Dynamics
        2.3.1 Insomnia Therapeutics Drugs Industry Trends
        2.3.2 Insomnia Therapeutics Drugs Market Drivers
        2.3.3 Insomnia Therapeutics Drugs Market Challenges
        2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
        3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2017-2022)
        3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
    3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
        3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2021
    3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
    3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
    3.7 Date of Enter into Insomnia Therapeutics Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
    4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2023-2028)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
    5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Insomnia Therapeutics Drugs Market Size (2017-2028)
    6.2 North America Insomnia Therapeutics Drugs Market Size by Type
        6.2.1 North America Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
        6.2.2 North America Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
        6.2.3 North America Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
    6.3 North America Insomnia Therapeutics Drugs Market Size by Application
        6.3.1 North America Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
        6.3.2 North America Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
        6.3.3 North America Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
    6.4 North America Insomnia Therapeutics Drugs Market Size by Country
        6.4.1 North America Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
        6.4.2 North America Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Insomnia Therapeutics Drugs Market Size (2017-2028)
    7.2 Europe Insomnia Therapeutics Drugs Market Size by Type
        7.2.1 Europe Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
    7.3 Europe Insomnia Therapeutics Drugs Market Size by Application
        7.3.1 Europe Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
    7.4 Europe Insomnia Therapeutics Drugs Market Size by Country
        7.4.1 Europe Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type
        8.2.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application
        8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region
        8.4.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Insomnia Therapeutics Drugs Market Size (2017-2028)
    9.2 Latin America Insomnia Therapeutics Drugs Market Size by Type
        9.2.1 Latin America Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
    9.3 Latin America Insomnia Therapeutics Drugs Market Size by Application
        9.3.1 Latin America Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
    9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country
        9.4.1 Latin America Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type
        10.2.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Insomnia Therapeutics Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application
        10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Insomnia Therapeutics Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country
        10.4.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Takeda Pharmaceutical Company Ltd.
        11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
        11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
        11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
        11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments
    11.2 Vanda Pharmaceuticals
        11.2.1 Vanda Pharmaceuticals Company Details
        11.2.2 Vanda Pharmaceuticals Business Overview
        11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
        11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.2.5 Vanda Pharmaceuticals Recent Developments
    11.3 Merck & Co., Inc.
        11.3.1 Merck & Co., Inc. Company Details
        11.3.2 Merck & Co., Inc. Business Overview
        11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
        11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.3.5 Merck & Co., Inc. Recent Developments
    11.4 Pfizer Inc.
        11.4.1 Pfizer Inc. Company Details
        11.4.2 Pfizer Inc. Business Overview
        11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
        11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.4.5 Pfizer Inc. Recent Developments
    11.5 Teva Pharmaceutical Industries Ltd.
        11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
        11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
        11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
    11.6 Mylan N.V.
        11.6.1 Mylan N.V. Company Details
        11.6.2 Mylan N.V. Business Overview
        11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
        11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.6.5 Mylan N.V. Recent Developments
    11.7 Sumitomo Dainippon Pharma Co., Ltd
        11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
        11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
        11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
        11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
        11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.8.5 Sanofi Recent Developments
    11.9 Paratek Pharmaceuticals Inc.
        11.9.1 Paratek Pharmaceuticals Inc. Company Details
        11.9.2 Paratek Pharmaceuticals Inc. Business Overview
        11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
        11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.9.5 Paratek Pharmaceuticals Inc. Recent Developments
    11.10 Ebb Therapeutics
        11.10.1 Ebb Therapeutics Company Details
        11.10.2 Ebb Therapeutics Business Overview
        11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
        11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2017-2022)
        11.10.5 Ebb Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Benzodiazepines
    Table 3. Key Players of Nonbenzodiazepines
    Table 4. Key Players of Antidepressants
    Table 5. Key Players of Orexin Antagonists
    Table 6. Key Players of Melatonin Antagonists
    Table 7. Key Players of Others
    Table 8. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2017-2022)
    Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2023-2028)
    Table 14. Insomnia Therapeutics Drugs Market Trends
    Table 15. Insomnia Therapeutics Drugs Market Drivers
    Table 16. Insomnia Therapeutics Drugs Market Challenges
    Table 17. Insomnia Therapeutics Drugs Market Restraints
    Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Insomnia Therapeutics Drugs Revenue Share by Players (2017-2022)
    Table 20. Global Top Insomnia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
    Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Insomnia Therapeutics Drugs Product Solution and Service
    Table 25. Date of Enter into Insomnia Therapeutics Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2017-2022)
    Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2023-2028)
    Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Insomnia Therapeutics Drugs Revenue Share by Application (2017-2022)
    Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Insomnia Therapeutics Drugs Revenue Share by Application (2023-2028)
    Table 35. North America Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Insomnia Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Insomnia Therapeutics Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Insomnia Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Takeda Pharmaceutical Company Ltd. Company Details
    Table 66. Takeda Pharmaceutical Company Ltd. Business Overview
    Table 67. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
    Table 68. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 69. Takeda Pharmaceutical Company Ltd. Recent Developments
    Table 70. Vanda Pharmaceuticals Company Details
    Table 71. Vanda Pharmaceuticals Business Overview
    Table 72. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
    Table 73. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 74. Vanda Pharmaceuticals Recent Developments
    Table 75. Merck & Co., Inc. Company Details
    Table 76. Merck & Co., Inc. Business Overview
    Table 77. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
    Table 78. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 79. Merck & Co., Inc. Recent Developments
    Table 80. Pfizer Inc. Company Details
    Table 81. Pfizer Inc. Business Overview
    Table 82. Pfizer Inc. Insomnia Therapeutics Drugs Product
    Table 83. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 84. Pfizer Inc. Recent Developments
    Table 85. Teva Pharmaceutical Industries Ltd. Company Details
    Table 86. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 87. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
    Table 88. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 89. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 90. Mylan N.V. Company Details
    Table 91. Mylan N.V. Business Overview
    Table 92. Mylan N.V. Insomnia Therapeutics Drugs Product
    Table 93. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 94. Mylan N.V. Recent Developments
    Table 95. Sumitomo Dainippon Pharma Co., Ltd Company Details
    Table 96. Sumitomo Dainippon Pharma Co., Ltd Business Overview
    Table 97. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
    Table 98. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 99. Sumitomo Dainippon Pharma Co., Ltd Recent Developments
    Table 100. Sanofi Company Details
    Table 101. Sanofi Business Overview
    Table 102. Sanofi Insomnia Therapeutics Drugs Product
    Table 103. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 104. Sanofi Recent Developments
    Table 105. Paratek Pharmaceuticals Inc. Company Details
    Table 106. Paratek Pharmaceuticals Inc. Business Overview
    Table 107. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
    Table 108. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 109. Paratek Pharmaceuticals Inc. Recent Developments
    Table 110. Ebb Therapeutics Company Details
    Table 111. Ebb Therapeutics Business Overview
    Table 112. Ebb Therapeutics Insomnia Therapeutics Drugs Product
    Table 113. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2017-2022) & (US$ Million)
    Table 114. Ebb Therapeutics Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Insomnia Therapeutics Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Benzodiazepines Features
    Figure 3. Nonbenzodiazepines Features
    Figure 4. Antidepressants Features
    Figure 5. Orexin Antagonists Features
    Figure 6. Melatonin Antagonists Features
    Figure 7. Others Features
    Figure 8. Global Insomnia Therapeutics Drugs Market Share by Application: 2021 VS 2028
    Figure 9. Prescription Case Studies
    Figure 10. Over-the-Counter (OTC) Case Studies
    Figure 11. Insomnia Therapeutics Drugs Report Years Considered
    Figure 12. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Insomnia Therapeutics Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Insomnia Therapeutics Drugs Market Share by Players in 2021
    Figure 16. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2021
    Figure 18. North America Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
    Figure 20. North America Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
    Figure 21. North America Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
    Figure 22. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
    Figure 28. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Insomnia Therapeutics Drugs Market Size Share by Region (2017-2028)
    Figure 38. China Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
    Figure 48. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Insomnia Therapeutics Drugs Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Insomnia Therapeutics Drugs Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Insomnia Therapeutics Drugs Market Size Share by Country (2017-2028)
    Figure 54. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Insomnia Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 58. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 59. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 60. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 62. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 63. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 64. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 65. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 66. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Frequently Asked Questions
Insomnia Therapeutics Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Insomnia Therapeutics Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Insomnia Therapeutics Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports